Ciljevi
Primary
- Collect all low-grade endometrioid ovarian carcinoma cases recorded in the French TMRG (“Tumeurs Malignes Rares Gynécologiques”) database.
- Describe clinical presentation at diagnosis, pathological features, treatment-related data and survival data (Progression-Free Survival and Overall Survival).
Secondary
- In patients with FFPE blocks available, we plan to evaluate the expression levels of proteins (tissue micro-array), mRNA (Nanostring nCounter® technology), and explore DNA single nucleotide variants and indels, and copy number alterations (whole exome sequencing).
- Correlate patient’s characteristics and outcomes to the protein, RNA, and DNA analyzes.
Voditelj obrade
Institut Paoli Calmettes
232 Boulevard Sainte Marguerite
13273 Marseille Cedex 09
Kategorije korištenih podataka
Données de santé / Données génétiques / Données médico-administratives
Origine de données utilisées
Soins
Institut Paoli Calmettes (Marseille)
2026
2027
2028
Populacija koja je predmet istraživanja ili obrade podataka
INCLUSION CRITERIA
- Patients with pathological and clinical data recorded in the “Observatoire Francophone des Tumeurs malignes Rares Gynécologiques” database.
- Pathological review by an expert pathologist from the TMRG network confirming the diagnosis of low-grade endometrioid carcinoma
- Diagnosis of ovarian carcinoma with a pure low-grade endometrioid histology.
- Synchronous low-grade endometrioid endometrial carcinoma FIGO stage IA are accepted.
- Signed consent to use data and biological samples.
- FFPE block available for inclusion in the translational part of the study.
NON INCLUSION CRITERIA
- Ovarian carcinoma with a mixed histology comprising a low-grade endometrioid component.
Pravna osnova
Traitement de données mené dans l'intérêt public dans le domaine de la santé publique (article 6.1e et 9.2.j du Règlement (UE) n°2016/679)
Interni i vanjski primatelji podataka
Institut Paoli Calmettes
Datum početka istraživanja
24/03/2026
Razdoblje čuvanja podataka
Les données seront conservées pendant la durée légale en vigueur ou tant qu'elles présenteront un intérêt scientifique